Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Oncogene

• Publication date

  1997-05-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1201098PMID 9191056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of Mitogen-activated Protein (MAP) Kinase Pathway by Pervanadate, a Potent Inhibitor of Tyrosine Phosphatases*

  1996cited by this paper
• Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization

  1996cited by this paper
• MKP-3, a Novel Cytosolic Protein-tyrosine Phosphatase That Exemplifies a New Class of Mitogen-activated Protein Kinase Phosphatase (*)

  1996cited by this paper
• The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.

  1996cited by this paper
• Protein kinase C beta 1 and protein kinase C beta 2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinoma cells.

  1996cited by this paper
• Requirement of an Upstream AP-1 Motif for the Constitutive and Phorbol Ester-inducible Expression of the Urokinase-type Plasminogen Activator Receptor Gene*

  1996cited by this paper
• Analysis of the ERK-stimulated ETS transcription factor ER81

  1996cited by this paper
• Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity

  1996cited by this paper
• Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

  1996cited by this paper
• Reversal of Raf-1 activation by purified and membrane-associated protein phosphatases.

  1995cited by this paper
• Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system: activation of Raf-1 leads to hypermodification of c-jun and c-fos via multiple pathways.

  1995cited by this paper
• Structure of the human urokinase receptor gene and its similarity to CD59 and the Ly-6 family.

  1995cited by this paper
• Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase Receptor (*)

  1995cited by this paper
• Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase receptor gene expression.

  1995cited by this paper
• Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase

  1995cited by this paper
• Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma.

  1995cited by this paper
• A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene.

  1995cited by this paper
• Basic fibroblast growth factor is a neurotropic factor in GT1 gonadotropin-releasing hormone neuronal cell lines.

  1995cited by this paper
• Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation

  1995cited by this paper
• Activation of Mitogen-activated Protein Kinase and Phosphatidylinositol 3′-Kinase Is Not Sufficient for the Hormonal Stimulation of Glucose Uptake, Lipogenesis, or Glycogen Synthesis in 3T3-L1 Adipocytes (*)

  1995cited by this paper
• Cellular Stresses Differentially Activate c-Jun N-terminal Protein Kinases and Extracellular Signal-regulated Protein Kinases in Cultured Ventricular Myocytes (*)

  1995cited by this paper
• PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*)

  1995cited by this paper
• Matrix/Integrin Interaction Activates the Mitogen-activated Protein Kinase, p44 and p42(*)

  1995cited by this paper
• Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.

  1995cited by this paper
• Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor in skeletal muscle cells.

  1995cited by this paper
• Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene.

  1995cited by this paper
• Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron

  1995cited by this paper
• Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549.

  1995cited by this paper
• Poly-L-ornithine-mediated transfection of human keratinocytes.

  1995cited by this paper
• Isolation and Characterization of a Novel Dual Specific Phosphatase, HVH2, Which Selectively Dephosphorylates the Mitogen-activated Protein Kinase (*)

  1995cited by this paper
• A synthetic inhibitor of the mitogen-activated protein kinase cascade.

  1995cited by this paper
• Vascular Endothelial Growth Factor Increases Urokinase Receptor Expression in Vascular Endothelial Cells (*)

  1995cited by this paper
• Urokinase receptor and colorectal cancer survival.

  1994cited by this paper
• The structure of the urokinase-type plasminogen activator receptor gene.

  1994cited by this paper
• Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA)

  1994cited by this paper
• The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.

  1994cited by this paper
• Activations of mitogen-activated protein kinases and phospholipase D in A7r5 vascular smooth muscle cells.

  1994cited by this paper
• Transcriptional activation of the urokinase receptor gene in invasive colon cancer

  1994cited by this paper
• Identification of the urokinase receptor as an adhesion receptor for vitronectin.

  1994cited by this paper
• RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2

  1994cited by this paper
• Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK.

  1994cited by this paper
• A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum.

  1994cited by this paper
• Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy.

  1994cited by this paper
• Transformation of mammalian cells by constitutively active MAP kinase kinase.

  1994cited by this paper
• Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasion

  1994cited by this paper
• Elk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase.

  1993cited by this paper
• Upregulation of urokinase receptor expression on migrating endothelial cells

  1993cited by this paper
• Raf-1 forms a stable complex with Mek1 and activates Mek1 by serine phosphorylation.

  1993cited by this paper
• Denaturing gradient gel electrophoresis (DGGE) assay for K-ras and N-ras genes: detection of K-ras point mutations in human lung tumour DNA.

  1993cited by this paper
• The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts.

  1993cited by this paper
• Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation.

  1993cited by this paper
• Prevention of metastasis by inhibition of the urokinase receptor.

  1993cited by this paper
• Requirement for Raf and MAP kinase function during the meiotic maturation of Xenopus oocytes

  1993cited by this paper
• Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line.

  1993cited by this paper
• An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator

  1993cited by this paper
• Divergence of signaling pathways for insulin in PC-12 pheochromocytoma cells.

  1993cited by this paper
• Assignment of the human urokinase receptor gene (PLAUR) to 19q13.

  1992cited by this paper
• The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product.

  1992cited by this paper
• Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.

  1992cited by this paper
• Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter

  1992cited by this paper
• Activation of the c-Raf protein kinase by protein kinase C phosphorylation.

  1992cited by this paper
• Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase

  1992cited by this paper
• Raf-1 activates MAP kinase-kinase

  1992cited by this paper
• Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator.

  1991cited by this paper
• Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes.

  1991cited by this paper
• Raf-1 protein kinase is required for growth of induced NIH/3T3 cells

  1991cited by this paper
• Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.

  1991cited by this paper
• Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor

  1991cited by this paper
• Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer.

  1991cited by this paper
• Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.

  1991cited by this paper
• The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.

  1991cited by this paper
• Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.

  1991cited by this paper
• Phosphorylation of c-jun mediated by MAP kinases

  1991cited by this paper
• Receptor‐mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI‐1.

  1990cited by this paper
• Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.

  1990cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• A ras-related gene with transformation suppressor activity.

  1989cited by this paper
• Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation.

  1989cited by this paper
• The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.

  1988cited by this paper
• Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines.

  1988cited by this paper
• A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.

  1988cited by this paper
• Autocrine saturation of pro-urokinase receptors on human A431 cells.

  1986cited by this paper
• The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin.

  1967cited by this paper

• Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025

  2025cites this paper
• ERO1α mediates endoplasmic reticulum stress-induced apoptosis via microRNA-101/EZH2 axis in colon cancer RKO and HT-29 cells

  2021cites this paper
• A light at the end of the tunnel

  2020cites this paper
• an overview of cancer-associated membrane proteins

  2017cites this paper
• Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins

  2016cites this paper
• Increases in intracellular calcium perturb blood-brain barrier via protein kinase C-alpha and apoptosis.

  2016cites this paper
• Critical Role of PepT1 in Promoting Colitis-Associated Cancer and Therapeutic Benefits of the Anti-inflammatory PepT1-Mediated Tripeptide KPV in a Murine Model

  2016cites this paper
• Oral Squamous Cell Carcinoma - Role of the Plasminogen Activation System in Tumour Progression.

  2015cites this paper
• Dietary gallic acid and anthocyanin cytotoxicity on human fibrosarcoma HT1080 cells. A study on the mode of action.

  2014cites this paper
• Molecular Mechanisms of Tumor Metastasis

  2013cites this paper
• Ecdysone receptor and ultraspiracle proteins are tyrosine phosphorylated during adult development of silkmoths.

  2012cites this paper
• Plasminogen Activators and Their Inhibitors in Cancer

  2012cites this paper
• Advantages of the AMDL-ELISA DR-70 (FDP) Assay over Carcinoembryonic Antigen (CEA) for Monitoring Colorectal Cancer Patients

  2010cites this paper
• Translational research on u-PAR.

  2010cites this paper
• The urokinase plasminogen activator system: a target for anti-cancer therapy.

  2009cites this paper
• The Cancer Degradome

  2009cites this paper
• The urokinase receptor as an entertainer of signal transduction.

  2009cites this paper
• Metastatic effect of LY-6K gene in breast cancer cells.

  2009cites this paper
• The Urokinase Plasminogen Activator Receptor as a Target for Cancer Therapy

  2008cites this paper
• Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.

  2008cites this paper
• Analysis of Specific Transcriptional Regulators as Early Predictors of Independent Prognostic Relevance in Resected Colorectal Cancer

  2007cites this paper
• MEK/ERK‐dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells

  2007cites this paper
• Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression

  2007cites this paper
• Molecular regulation of an invasion-related molecule--options for tumour staging and clinical strategies.

  2006cites this paper
• Interleukin-1α enhances the aggressive behavior of pancreatic cancer cells by regulating the α6β1-integrin and urokinase plasminogen activator receptor expression

  2006cites this paper
• Comparison of the mechanisms of action of three cancer chemopreventive flavonoids

  2006cites this paper
• Plasticity in urokinase-type plasminogen activator receptor (uPAR) display in colon cancer yields metastable subpopulations oscillating in cell surface uPAR density--implications in tumor progression.

  2006cites this paper
• Urokinase-Receptor (u-PAR)–An Essential Player in Multiple Games of Cancer: A Review on Its Role in Tumor Progression, Invasion, Metastasis, Proliferation/dormancy, Clinical Outcome and Minimal Residual Disease

  2006cites this paper
• Regulation and Clinical Significance of Urokinase-Receptor (u-PAR), an Invasion-Related Molecule

  2006cites this paper
• Expression Cloning Identifies Transgelin (SM22) as a Novel Repressor of 92-kDa Type IV Collagenase (MMP-9) Expression*

  2006cites this paper
• Role of Urokinase-Type Plasminogen Activator Receptor in Human Glioma Invasion

  2005cites this paper
• In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.

  2005cites this paper
• Transcriptional and posttranscriptional regulation of the plasminogen activator system

  2005cites this paper
• Molecular mechanisms of hepatic metastasis in colorectal cancer

  2005cites this paper
• Combination Analysis of Activator Protein-1 Family Members, Sp1 and an Activator Protein-2α-Related Factor Binding to Different Regions of the Urokinase Receptor Gene in Resected Colorectal Cancers

  2005cites this paper
• Ascites induces modulation of α6β1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma

  2005cites this paper
• The urokinase receptor and the regulation of cell proliferation

  2005cites this paper
• Differential Regulation of Membrane Type 1-Matrix Metalloproteinase Activity by ERK 1/2- and p38 MAPK-modulated Tissue Inhibitor of Metalloproteinases 2 Expression Controls Transforming Growth Factor-β1-induced Pericellular Collagenolysis*

  2004cites this paper
• The Ras Signaling Pathway in Mammary Tumorigenesis and Metastasis

  2004cites this paper
• Proteomic profiling of proteins associated with urokinase plasminogen activator receptor in a colon cancer cell line using an antisense approach

  2003cites this paper
• ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).

  2003cites this paper
• Transcriptional Regulation of the Urokinase Receptor (u-PAR) – A Central Molecule of Invasion and Metastasis

  2003influential citation
• Molecular regulation of urokinase-receptor gene expression as one potential concept for molecular staging and therapy.

  2003cites this paper
• Molecular Staging of Cancer

  2003cites this paper
• Type-2A protein phosphatase activity is required to maintain death receptor responsiveness

  2003cites this paper
• ERKMAPK Activity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK

  2003cites this paper
• Hydrogen peroxide mediates arsenite activation of p70(s6k) and extracellular signal-regulated kinase.

  2003cites this paper
• HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model

  2002cites this paper
• RPR‐115135, a farnesyltransferase inhibitor, increases 5‐FU‐ cytotoxicity in ten human colon cancer cell lines: Role of p53

  2002cites this paper
• Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.

  2002cites this paper
• Association between αvβ6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen‐dependent matrix degradation in ovarian cancer

  2002cites this paper
• Veränderung des Mitogen - activated protein kinase - Signaltransduktionsweges in der Plazenta von Patientinnen mit Präeklampsie

  2001cites this paper
• Glioma cells deficient in urokinase plaminogen activator receptor expression are susceptible to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis.

  2001cites this paper
• Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells.

  2001cites this paper
• β3A-Integrin Downregulates the Urokinase-Type Plasminogen Activator Receptor (u-PAR) through aPEA3/ets Transcriptional Silencing Element in the u-PAR Promoter

  2001cites this paper
• The role and regulation of urokinase‐type plasminogen activator receptor gene expression in cancer invasion and metastasis

  2001cites this paper
• Prognostic Significance of the Combined Expression of Matrix Metalloproteinase-9, Urokinase Type Plasminogen Activator and its Receptor in Breast Cancer as Measured by Northern Blot Analysis

  2001cites this paper
• Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

  2001cites this paper
• Recombinant Toxins That Bind to the Urokinase Receptor Are Cytotoxic without Requiring Binding to the α2-Macroglobulin Receptor*

  2000cites this paper
• Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion.

  2000cites this paper
• Downregulation of a Mitogen‐Activated Protein Kinase Signaling Pathway in the Placentas of Women With Preeclampsia

  2000cites this paper
• Activation Mechanisms of the Urokinase-type Plasminogen Activator Promoter by Hepatocyte Growth Factor/Scatter Factor*

  1999cites this paper
• Angiostatin Diminishes Activation of the Mitogen-Activated Protein Kinases ERK-1 and ERK-2 in Human Dermal Microvascular Endothelial Cells

  1999cites this paper
• PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma

  1999cites this paper
• Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype.

  1999cites this paper
• Targeted disruption of the K-Ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis

  1999cites this paper
• Increased Ser-10 Phosphorylation of Histone H3 in Mitogen-stimulated and Oncogene-transformed Mouse Fibroblasts*

  1999cites this paper
• RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases

  1999cites this paper
• Inhibition of Mitogen-Activated Kinase Signaling Sensitizes HeLa Cells to Fas Receptor-Mediated Apoptosis

  1999cites this paper
• Secretion of urokinase and metalloproteinase‐9 induced by staurosporine is dependent on a tyrosine kinase pathway in mammary tumor cells

  1998cites this paper
• Urokinase receptor is a key player in tumour progression

  1998cites this paper
• Effects of dietary fiber on the rat intestinal mucosa exposed to low doses of a carcinogen.

  1998cites this paper
• Does laser lithotripsy hit the target?

  1998cites this paper
• Tumor Promoter Arsenite Activates Extracellular Signal-Regulated Kinase through a Signaling Pathway Mediated by Epidermal Growth Factor Receptor and Shc

  1998cites this paper
• Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility*

  1998cites this paper
• Progress in idiopathic bile acid malabsorption

  1998cites this paper
• A light at the end of the tunnel

  1998cites this paper
• Vanadium induces AP-1- and NFkappB-dependent transcription activity.

  1998cites this paper
• The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression.

  1998cites this paper
• Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules

  1998cites this paper